medigraphic.com
SPANISH

Gaceta Médica de México

ISSN 0016-3813 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2003, Number 2

<< Back Next >>

Gac Med Mex 2003; 139 (2)

Acute Leukemias in Children

I. Introduction.
II. Treatment of Acute Myeloblastic Leukemias in Children.
III. Elective Suspension of Chemotherapy in Acute Lymphoblastic Leukemia.

Paredes-Aguilera R, Ortega-Aramburu JJ
Full text How to cite this article

Language: Spanish
References: 20
Page: 113-118
PDF size: 53.08 Kb.


Key words:

No keywords

Text Extraction

No abstratc


REFERENCES

  1. Creutzig U, Zimmermann M, Ritter J, Henze G, Graf N , Schellong G . Definition of a standard-risk group in children with AML. Br J Haematol 1999;104:630-9

  2. Creutzig U, Ritter J, Zimmermann M, Reinhardt D, Hermann J, Berthold F et al, for the AML-BFM study group. Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: results of study Acute Myeloid Leukemia-Berlin-Frankfurt-Münster 93. J Clin Oncol 2001;19:2705-13

  3. Stevens RF, Hann MI, Wheatley K, Gray RG on behalf of the MRC Childhood Leukaemia Working Party. Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukaemia : results of the United Kingdom Medical Research Council´s 10th AML trial. Br J Haemat 1998;101:130-40.

  4. Michel G, Leverger G, Leblanc T, Nelken B, Baruchel A, Landman Parker et al. Allogeneic bone marrow transplantation vs aggressive post-remission chemotherapy for children with acute myeloid leukemia on first complete remission. A prospective study from the French Society of Pediatric Hematology and Immunology. Bone Marrow Transplant 1996;17:191-6

  5. Woods WG, Neudorf S, Gold S, Sanders J, Buckley JD, Barnard DR et al. A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation and aggressive chemotherapy in children with acute myeloid leukemia in remission: a report from the Children´s Cancer Group. Blood 2001;97:56-62.

  6. Gorin NC (review article). Autologous stem cell transplantation in acute myeloid leukemia. Blood 1998;92:1073-90.

  7. Miller CB, Rowlings RA, Zhang MJ, Jones RJ, Piantadosi S, Keating A et al. The effect of graft purging with 4-hydroperoxyxyclophosphamide in autologous bone marrow transplantation for acute myelogenous leukemia. Exper. Hematology 2001; 29:1336-46

  8. Sanz MA, Martin G, Rayon C, Esteve J, González M, Díaz-Mediavilla J et al. A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RAR-alpha-positive acute promyelocytic leukemia. Blood 1999;94:3015-21

  9. George SL, Rhomes JA, Mauer AM, Simone JV. A reappraisal of the results of stopping therapy in childhood leukemia. N Engl J Med 1979;300:269-273.

  10. Land VJ, Berry DH, Herson J, et al. Long –term survival in childhood acute leukemia. Med Ped Oncol 1979;7:19-24.

  11. Baum E, Sather H, Nachman J, et al. Relapse rates following cessation of chemotherapy during complete remission of acute lymphocytic leukemia. Med Ped Oncol 1979;7:25-34.

  12. 253 Mandelli F, Amadori S, Cantu-Rajnoldi A, et al. Discontinuing therapy in childhood acute lymphocytic leukemia. Cancer 1980;46:1319-1323.

  13. Hardisty RM, Till MM, Peto J. Acute lymphoblastic leukaemia: four-year survivals old and new. J Clin Pathol 1981;34:249-

  14. Conter V, Arico M, Valsecchi MG, et al. Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Acute Lymphoblastic Leukemia Studies, 1982-1995. Leukemia (2000) 14;2196-2204.

  15. Shrappe M, Reiter A, Zimmermann M. et al. Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Leukemia (2000) 14;2205-2222.

  16. Gaynon PS, Trigg ME, Neerema NA, et al. Children’s Cancer Group trials in childhood acute lymphoblastic leukemia: 1983- 1995. Leukemia (2000) 14;2223-2233.

  17. Maloney KW, Shuster JJ, Murphy S, et al. Long-term results of treatment studies for childhood acute lymphoblastic leukemia: Pediatric Oncology Group studies from 1986-1994. Leukemia (2000) 14;2276-2285.

  18. Pui C-H, Boyett JM, Rivera GK, et al. Long-term results of Total Therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children’s Research Hospital. Leukemia (2000) 14;2286-2294.

  19. Silverman LB, Declerck L, Gelber RD, et al. Results of Dana-Farber Cancer Institute Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981-1995) Leukemia (2000);14:2247-2256.

  20. Chessels J. Relapsed acute lymphoblastic leukemia: Bone marrow transplant or conventional treatment? Hematology ASH;2000:291-302.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Gac Med Mex. 2003;139